bharat biotech

Bharat Biotech is an Indian biotechnology company headquartered in Hyderabad, Telangana. Founded in 1996 by Dr. Krishna Ella, Bharat Biotech is known for its innovation in the development, production, and distribution of vaccines and biotherapeutics. The company has a strong track record in vaccine research and has developed several vaccines that are used globally to combat infectious diseases.

Bharat Biotech gained significant international attention during the COVID-19 pandemic for developing Covaxin, one of India's first indigenous COVID-19 vaccines. Covaxin was developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). It played a crucial role in India's vaccination drive against the coronavirus and was also exported to several countries as part of India's vaccine diplomacy efforts.

The company is also involved in the development of vaccines for other diseases, including hepatitis B, rotavirus, typhoid, and chikungunya. Bharat Biotech's contributions to public health have been recognized globally, and it continues to be a key player in the biotechnology sector, particularly in the field of vaccines and immunology.

A viral news clipping that was being falsely circulated as evidence of side effects related to the COVID-19 vaccine developed by Bharat Biotech.

BOOM found that the newspaper clipping, originally published by Hindustan Times, actually reported on side effects seen among children after they were administered the measles-rubella vaccine in 2018. The clipping was misleadingly linked to the COVID-19 vaccine, spreading misinformation about vaccine safety.